Related Experiment Video
Updated: Aug 10, 2026
11:55
Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade
Published on: March 14, 2011
[Neonatal alloimmune thrombopenia in anti-HPA-3a (Baka) immunization]
M Mokhtari1, C Kaplan, E Gourrier
1Unité de réanimation pédiatrique, hôpital Saint-Vincent-de-Paul, Paris, France.
Summary
Neonatal alloimmune thrombocytopenia (NAIT) caused by HPA-3a incompatibility is more common than previously thought. Early detection and treatment are crucial for managing this serious condition in newborns.
Area of Science:
- Hematology
- Immunology
- Neonatology
Background:
- Neonatal alloimmune thrombocytopenia (NAIT) is a condition affecting newborns, with HPA-3a incompatibility accounting for a small percentage of cases.
- This case highlights a severe presentation of NAIT due to HPA-3a incompatibility.
Observation:
- A male infant presented with extensive petechiae, purpura, and severe thrombocytopenia (8,000/mm3) shortly after birth.
- The infant received exchange transfusion, random donor platelets, intravenous immunoglobulin (IVIg), and corticosteroids for treatment.
- Symptoms resolved without relapse after treatment discontinuation.
Findings:
- Diagnosis of neonatal alloimmune thrombocytopenia with HPA-3a (Baka) incompatibility was confirmed.
- The case demonstrates a successful management of severe NAIT.
Implications:
- HPA-3a incompatibility should be considered in all cases of neonatal thrombocytopenia, as it may be underdiagnosed.
- Increased awareness and testing for HPA-3a incompatibility can improve diagnosis and outcomes for affected newborns.
Related Concept Videos
02:45Blood Transfusion and Agglutination
Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
01:19Rh Blood Group
The Rhesus (Rh) antigen is crucial in determining blood groups and ensuring compatibility during blood transfusions.
01:22Development of Immunocompetence
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
01:22Bacterial Meningitis I: Introduction
Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...